• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[苏联新型抗炎制剂奥索芬的临床药理学]

[Clinical pharmacology of the new Soviet anti-inflammatory preparation ortofen].

作者信息

Kukes V G, Murashko V V, Iagunina M V, Volchenok V I, Pokryshkin V I

出版信息

Ter Arkh. 1988;60(3):105-9.

PMID:3388258
Abstract

Comparative pharmacokinetic and pharmacodynamic studies on ortophen, a new Soviet antiinflammatory drug, and voltaren (Ciba-Geigy, Switzerland) were carried out in 73 patients with rheumatoid arthritis. Pharmacokinetics of both drugs was studied in 19 patients (9 patients were given voltaren, 10--ortophen). Pharmacokinetic difference was statistically indistinguishable. The comparison of the principal routine subjective and objective pharmacodynamic indices revealed no significant difference between ortophen and voltaren action. The new drug was shown to possess a high analgetic and antiinflammatory activity.

摘要

对一种新的苏联抗炎药物邻甲酚酞和扶他林(瑞士汽巴 - 嘉基公司生产)进行了比较药代动力学和药效学研究,研究对象为73例类风湿性关节炎患者。在19例患者中研究了两种药物的药代动力学(9例给予扶他林,10例给予邻甲酚酞)。两种药物的药代动力学差异在统计学上无显著意义。对主要常规主观和客观药效学指标的比较显示,邻甲酚酞和扶他林的作用无显著差异。结果表明,这种新药具有很高的镇痛和抗炎活性。

相似文献

1
[Clinical pharmacology of the new Soviet anti-inflammatory preparation ortofen].[苏联新型抗炎制剂奥索芬的临床药理学]
Ter Arkh. 1988;60(3):105-9.
2
[The pharmacokinetics of the new Russian prolonged-action form of diclofenac sodium--Ortopek--in a single oral dose].[俄罗斯新型双氯芬酸钠长效剂型——奥拓派克——单次口服剂量的药代动力学]
Eksp Klin Farmakol. 1995 Jan-Feb;58(1):53-4.
3
[Voltaren gel in the combined treatment of patients with psoriatic arthritis].
Vestn Dermatol Venerol. 1990(10):55-7.
4
Diclofenac combined with cyclosporine in treatment refractory rheumatoid arthritis: longitudinal safety assessment and evidence of a pharmacokinetic/dynamic interaction.
J Rheumatol. 1996 Dec;23(12):2033-8.
5
Comparison of three therapeutic regimens using nonsteroidal antirheumatic drugs in patients with rheumatoid arthritis.类风湿关节炎患者使用非甾体类抗风湿药物的三种治疗方案比较。
Z Rheumatol. 1981 Jul-Aug;40(4):165-70.
6
[Experimental study of the interaction of nonsteroidal anti-inflammatory agents--voltaren and acetylsalicylic acid--with beta-adrenoblockers].[非甾体抗炎药——扶他林和乙酰水杨酸——与β-肾上腺素能阻滞剂相互作用的实验研究]
Biull Eksp Biol Med. 1984 Jul;98(7):48-51.
7
Bioavailability and pharmacokinetic properties of 2 sustained-release formulations of diclofenac sodium, Voltaren vs inflaban: effect of food on inflaban bioavailability.双氯芬酸钠两种缓释制剂(扶他林与英纷)的生物利用度和药代动力学特性:食物对英纷生物利用度的影响
Int J Clin Pharmacol Ther. 1996 Dec;34(12):564-70.
8
[Clinical experiences and results of clinical experimental studies with Voltaren in rheumatic diseases].
Wien Med Wochenschr. 1976 Mar 5;126(10):132-7.
9
[The efficacy of diclonate P in psoriatic arthritis].
Ter Arkh. 1994;66(5):75-7.
10
[Voltaren--the gold standard].
Reumatizam. 2000;47(2):29-31.